Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 15 Issue 3

TABLE OF CONTENTS Volume 15, Issue 3 (September 2012) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Why publish in the Asian Journal of Andrology? Efficient peer-review, hassle-free submission, recognition... Papers benefit from wide readership through hosting on nature.com and inclusion in the leading abstracting and indexing services. Rapid publication is also assured through Advance Online Publication. Review the complete list of AJA Author Benefits and submit your next article today!   Reviews Top Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior G Gueron, A De Siervi and E Vazquez Prostate Cancer Prostatic Dis 2012 15: 213-221; advance online publication, December 20, 2011; 10.1038/pcan.2011.64 Abstract | Full Text Role of 5α-reductase inhibitors in benign prostatic diseases F Azzouni and J Mohler Prostate Cancer Prostatic Dis 2012 15: 222-230; advance online publication, February 14, 2012; 10.1038/pcan.2012.1 Abstract | Full Text Role of denosumab in prostate cancer S Helo, J P Manger and T L Krupski Prostate Cancer Prostatic Dis 2012 15: 231-236; advance online publication, February 28, 2012; 10.1038/pcan.2012.2 Abstract | Full Text Original Articles Top Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy C Sevilla, S L Maliski, L Kwan, S E Connor and M S Litwin Prostate Cancer Prostatic Dis 2012 15: 237-243; advance online publication, January 31, 2012; 10.1038/pcan.2011.71 Abstract | Full Text MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case–control studies X-L Li and J-H Xu Prostate Cancer Prostatic Dis 2012 15: 244-249; advance online publication, February 28, 2012; 10.1038/pcan.2012.5 Abstract | Full Text Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro J Mani, S Vallo, K Barth, J Makarević, E Juengel, G Bartsch, C Wiesner, A Haferkamp and R A Blaheta Prostate Cancer Prostatic Dis 2012 15: 250-255; advance online publication, March 27, 2012; 10.1038/pcan.2012.9 Abstract | Full Text Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry A Blana, C N Robertson, S C W Brown, C Chaussy, S Crouzet, A Gelet, G N Conti, R Ganzer, G Pasticier, S Thuroff and J F Ward Prostate Cancer Prostatic Dis 2012 15: 256-259; advance online publication, April 10, 2012; 10.1038/pcan.2012.10 Abstract | Full Text Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model H-W Chen, Y-F Chang, H-Y Chuang, W-T Tai and J-J Hwang Prostate Cancer Prostatic Dis 2012 15: 260-264; advance online publication, May 8, 2012; 10.1038/pcan.2012.15 Abstract | Full Text Body mass index and risk of BPH: a meta-analysis S Wang, Q Mao, Y Lin, J Wu, X Wang, X Zheng and L Xie Prostate Cancer Prostatic Dis 2012 15: 265-272; advance online publication, December 20, 2011; 10.1038/pcan.2011.65 Abstract | Full Text The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study C Chong, L Fong, R Lai, W K O Lau, M Hartmann and S E Chia Prostate Cancer Prostatic Dis 2012 15: 273-277; advance online publication, February 21, 2012; 10.1038/pcan.2011.69 Abstract | Full Text Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy R Dittrich, J Kurth, E A Decelle, E M DeFeo, M Taupitz, S Wu, C-l Wu, W S McDougal and L L Cheng Prostate Cancer Prostatic Dis 2012 15: 278-282; advance online publication, January 31, 2012; 10.1038/pcan.2011.70 Abstract | Full Text A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008 D M Marcus, M Goodman, A B Jani, A O Osunkoya and P J Rossi Prostate Cancer Prostatic Dis 2012 15: 283-288; advance online publication, February 21, 2012; 10.1038/pcan.2012.4 Abstract | Full Text Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy M Kamrava, A H Kesarwala, R A Madan, E Lita, A Kaushal, K-Y Tsang, D J Poole, S M Steinberg, T Ferrara, W Dahut, J Schlom and J L Gulley Prostate Cancer Prostatic Dis 2012 15: 289-295; advance online publication, March 6, 2012; 10.1038/pcan.2012.7 Abstract | Full Text Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy U W Tunn, G Canepa, A Kochanowsky and E Kienle Prostate Cancer Prostatic Dis 2012 15: 296-302; advance online publication, June 26, 2012; 10.1038/pcan.2012.12 Abstract | Full Text Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial P-L Kellokumpu-Lehtinen, M Hjälm-Eriksson, C Thellenberg-Karlsson, L Åström, L Franzen, T Marttila, M Seke, M Taalikka and C Ginman for the SPCG-13 Prostate Cancer Prostatic Dis 2012 15: 303-307; advance online publication, May 1, 2012; 10.1038/pcan.2012.13 Abstract | Full Text Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer R B Egerdie, F Saad, M R Smith, T L J Tammela, J Heracek, P Sieber, C Ke, B Leder, R Dansey and C Goessl Prostate Cancer Prostatic Dis 2012 15: 308-312; advance online publication, May 29, 2012; 10.1038/pcan.2012.18 Abstract | Full Text Advertisement Ensure your access to APS Does your institution already subscribe to Clinical Pharmacology and Therapeutics, The Pharmacogenomics Journal and Nature Reviews Drug Discovery? If so - help your institution complete their collection with APS. Recommend APS today.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.